Blue Water Life Science Advisors, LP Guardant Health, Inc. Transaction History

Blue Water Life Science Advisors, LP

$103 Million
Q3 2025

A detailed history of Blue Water Life Science Advisors, LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 405,647 shares of GH stock, worth $38.3 Million. This represents 24.56% of its overall portfolio holdings.

Number of Shares

405,647

Previous 439,047 7.61%

Holding current value

$38.3 Million

Previous $22.8 Million 10.92%

% of portfolio

24.56%

Previous 18.09%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$40.98 - $67.42 $1.37 Million - $2.25 Million	-33,400 Reduced 7.61%	405,647 $25.3 Million
Q2 2025 Aug 14, 2025	SELL	$37.05 - $52.04 $9.45 Million - $13.3 Million	-255,000 Reduced 36.74%	439,047 $22.8 Million
Q4 2024 Feb 13, 2025	BUY	$20.2 - $38.11 $4.91 Million - $9.26 Million	243,000 Added 53.87%	694,047 $21.2 Million
Q3 2024 Nov 14, 2024	SELL	$22.3 - $36.29 $2.68 Million - $4.35 Million	-120,000 Reduced 21.01%	451,047 $10.3 Million
Q4 2023 Feb 14, 2024	SELL	$21.58 - $29.5 $2.27 Million - $3.1 Million	-105,000 Reduced 15.53%	571,047 $15.4 Million

Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $3.89 Million - $7.05 Million	185,602 Added 37.84%	676,047 $24.2 Million
Q1 2023 May 15, 2023	SELL	$22.92 - $33.76 $8.66 Million - $12.8 Million	-378,000 Reduced 43.53%	490,445 $11.5 Million
Q4 2022 Feb 14, 2023	SELL	$25.44 - $59.78 $2.8 Million - $6.58 Million	-110,000 Reduced 11.24%	868,445 $23.6 Million
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $6.3 Million - $8.8 Million	144,300 Added 17.3%	978,445 $52.7 Million
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $4.98 Million - $13.4 Million	172,700 Added 26.11%	834,145 $33.6 Million
Q1 2022 May 18, 2022	BUY	$48.25 - $100.49 $13.1 Million - $27.2 Million	270,500 Added 69.19%	661,445 $43.8 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $23.4 Million - $31.8 Million	264,121 Added 208.26%	390,945 $39.1 Million
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $10.2 Million - $13.7 Million	-103,771 Reduced 45.0%	126,824 $15.9 Million
Q2 2021 Aug 13, 2021	BUY	$109.77 - $165.68 $4.97 Million - $7.5 Million	45,265 Added 24.42%	230,595 $28.6 Million
Q1 2021 May 14, 2021	BUY	$127.04 - $179.1 $5.64 Million - $7.96 Million	44,430 Added 31.53%	185,330 $28.3 Million
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $14.1 Million - $19.2 Million	140,900 New	140,900 $18.2 Million

Others Institutions Holding GH

# of Institutions

451

Shares Held

125M

Call Options Held

2.18M

Put Options Held

2.69M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $9.65B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Water Life Science Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Blue Water Life Science Advisors, LP with notifications on news.

Account

Blue Water Life Science Advisors, LP Guardant Health, Inc. Transaction History